Emily Hirata • UCSF Profiles

Emily Hirata, PhD

Title(s)	Associate Professor, Radiation Oncology
School	School of Medicine
Phone	--
ORCID	0000-0001-9350-5849
vCard	Download vCard

Overview

Dr. Hirata's clinical interests range from high dose rate brachytherapy and external beam photon radiotherapy, including specialized systems such as TomoTherapy. She is also interested in quality assurance and safety practices, developing workflows to improve efficiency and communication with a focus on optimization and automation.

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Prospective Clinical Validation of Virtual Patient-Specific Quality Assurance of Volumetric Modulated Arc Therapy Radiation Therapy Plans. Int J Radiat Oncol Biol Phys. 2022 08 01; 113(5):1091-1102. Wall PDH, Hirata E, Morin O, Valdes G, Witztum A. PMID: 35533908.

View in: PubMed Mentions: Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans
Use of Receiver Operating Curve Analysis and Machine Learning With an Independent Dose Calculation System Reduces the Number of Physical Dose Measurements Required for Patient-Specific Quality Assurance. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):1086-1095. Hasse K, Scholey J, Ziemer BP, Natsuaki Y, Morin O, Solberg TD, Hirata E, Valdes G, Witztum A. PMID: 33197530; PMCID: PMC9758537.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans
In Reply to von Eyben et al. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):467-8. Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. PMID: 26383685.

View in: PubMed Mentions: Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans
Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1017-25. Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. PMID: 25832692; PMCID: PMC4405528.

View in: PubMed Mentions: 10 Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans
Low dose fraction behavior of high sensitivity radiochromic film. Med Phys. 2005 Apr; 32(4):1054-60. Hirata EY, Cunningham C, Micka JA, Keller H, Kissick MW, DeWerd LA. PMID: 15895590.

View in: PubMed Mentions: 3 Fields:
Bio Biophysics Phy Physics Rad Radiology Rad Radiotherapy